ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,464.62
-0.16%
US Tech 100
19,220.00
-0.20%
다우존스 지수
39,150.33
0.04%
Bitcoin
64,090.82
-0.24%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Phoenix Biotech Aquisition Corporation (PBAXU)

  7. Phoenix Biotech Aquisition Corporation (PBAXU) 뉴스

PBAXU

Phoenix Biotech Aquisition (PBAXU)

Phoenix Biotech Aquisition Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:PBAXU
일자시간출처헤드라인심볼기업
2024/06/0606:13Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/05/2221:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/05/1806:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/05/1619:28Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/05/0706:11Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/05/0405:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/05/0213:16Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/05/0205:45Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/05/0205:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/04/2705:31Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/04/1605:36Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/04/1105:06Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/04/0406:27Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/04/0220:12Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/04/0220:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/04/0210:54Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/03/2810:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/03/2810:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/02/2823:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/02/2722:27Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/02/2711:37Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/02/2407:13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/02/2107:18Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/02/1709:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/02/1709:29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/02/1709:28Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/02/1502:14Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/02/1502:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/02/1306:16Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
2024/02/1306:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
 검색 관련기사 보기:NASDAQ:PBAXU

최근 히스토리

USOTC
HOCFF
Hochtief (PK)
BIT
UC4VD5
Unicredit Bank
USOTC
CPYYF
Centrica (PK)
NYSE
NCA
Nuveen California Munici...
USOTC
TRFE
Trustfeed (PK)
TG
FUP
Fuji Pharma
TG
CZ40M3
Commerzbank
GATE
CRE8USDT
Creaticles
USOTC
NISUY
Nissui (PK)
LSE
83WW
Rentokil 33
LSE
82EV
Ngg Fin 73
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유